Cocoon
Duct Occluder
KEY HIGHLIGHTS
Hat shaped tapered design ensures secired implantation at aorta and minimizes risk of mirgration in pulmonary artey
Device is filled with polyester fabric to assist thrombogenicity
Extended retention portion provides proper positioning of the device in ductus arteriosusÂ
100% occlusion rate at one month follow up
- Ability to recapture and redeploy
The Nitinol wire used in Cocoon Occluders is Coated with Platinum atoms (upto 25 microns) using nano fusion Technology by Plasma Deposition.
The Nitinol wire used in Cocoon Occluders is Coated with Platinum atoms (upto 25 microns) using nano fusion Technology by Plasma Deposition.
Cocoon
VSD Occluders
KEY HIGHLIGHTS
Self- expanding, Double disc device with unique Platinum coating
4,7& 10 mm waist length available
Available in multiple length to match the types and location of ventricular septal defects to close membranous and muscular defectsÂ
Discs are filled with polypropylene fabric which assists thrombogenicity
- Ability to recapture and redeploy
Cocoon
Septal Occluder
KEY HIGHLIGHTS
Self-expanding, self -centering double disc device with unique platinum cocated nitinol wire mesh
Both discs are connected by a waist at the center
Discs are filled with polypropylene fabric which assists thrombogenicity
95 to 100% Device sucess rate from early Europeans experience
- Ability to recapture and redeploy
0% Erosion up to 43 months of follow up in more than 4000 patients
The Nitinol wire used in Cocoon Occluders is Coated with Platinum atoms (upto 25 microns) using nano fusion Technology by Plasma Deposition.
The Nitinol wire used in Cocoon Occluders is Coated with Platinum atoms (upto 25 microns) using nano fusion Technology by Plasma Deposition.
Cocoon
Septal Occluder
No Compromise
KEY HIGHLIGHTS
Self-expanding, self -centering double disc device with unique platinum coating
Discs are filled with polypropylene fabric which assists thrombogenicity
95 to 100% Device sucess rate from early Europeans experience
- Ability to recapture and redeploy
0% Erosion up to 43 months of follow up in more than 4000 patients